Reporter-based cytotoxicity of anti-HER2 IgG variants.
收藏数据链接：
官方服务：
资源简介：
Reporter-based cytotoxicity of anti-HER2 IgG variants.
应用场景：
创建时间：
2016-06-21
相关数据集
Data Sheet 1_Affibody-based targeting agent 131I-YZHER2: V2 for HER2-positive ovarian cancer xenografts.doc
BackgroundThe human epidermal growth factor receptor 2 (HER2) affibodies are multifunctional tools that, when labeled with radioactive isotopes, hold significant potential for the diagnosis and treatm
NIAID Data Ecosystem20
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2 Descriptor: Designed Ankyrin Repeat Protein H10-2-G, Receptor tyro
Protein Data Bank Japan2024-11-13 更新10
Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans
Recently, the absence of a core-fucose residue in the N-glycan has been implicated to be important for enhancing antibody-dependent cellular cytotoxicity (ADCC) activity of immunoglobulin G monoclonal
Taylor & Francis Group2017-12-15 更新00
External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator
Overproduction of the Her2 oncoprotein has been found in ≈30% of breast tumors, and patients who have Her2 excesses typically have more aggressive disease. Here we show that the expression of the Her2
PubMed Central2002-09-19 更新10
DataSheet_1_Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen.docx
Bacillus Calmette–Guérin (BCG) is the gold standard adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). However, given the current global shortage of BCG, new treatments are needed. We
NIAID Data Ecosystem10
